Coverage with evidence development

From Glossary for Health Technology Lifecycle by EuroScan
Revision as of 12:56, 21 November 2023 by Admin1 (talk | contribs)

(diff) ← Older revision | Approved revision (diff) | Latest revision (diff) | Newer revision → (diff)

Early funding of a health technology conditional on gathering additional evidence to address the sources of uncertainty.

Note 1: The uncertainty usually relates to a specific aspect of the effectiveness or cost-effectiveness.

Note 2: Synonyms include access with evidence development, and managed access.

Note 3: Related terms include managed entry scheme/agreement, risk share agreement, interim funding, evidence development, conditional reimbursement, and conditional coverage.

References

http://htaglossary.net/coverage-with-evidence-development